ABSTRACT
Objective: To evaluate oral hygiene habits and periodontal disease status with teledentistry and to compare oral hygiene and periodontal disease status according to the COVID-19 history. Materials and Methods: Patients who had applied to our faculty before the pandemic and were reached via teledentistry were included. A questionnaire consisting of 4 sections and 25 questions was administered through telephone conversation. Demographic information, medical history, smoking habits, and COVID-19 history (with [COVID(+)] or without COVID-19 [COVID(-)]) were questioned in the first section, while dental hygiene (DH), environmental dental hygiene (EH), history of periodontal disease (PH) were evaluated in the next three sections. The answers were scored in a way that increased values symbolize negative attitude. Taking into account the minimum and maximum values that can be obtained from the sum of the scores;DH, EH and PH scales with low, medium and high value ranges were created. The groups were compared in terms of the mean value from the scales and the distribution in the scale ranges.
ABSTRACT
Aim: Our aim was to find out the knowledge, attitudes, and practices of university students regarding the COVID-19 pandemic, as well as to evaluate their vaccination status and the students' approaches to COVID-19 vaccination. Methods: Our cross-sectional study was carried out in the province of Tokat between 01 December 2021 and 31 December 2021. The sample of the research consists of Tokat Gaziosmanpasa University students. The students were reached by sending an online survey to their corporate e-mails. The survey form consists of socio-demographic data and parts regarding knowledge, attitudes, and practices towards COVID-19 and vaccines. Results: Our study included 1053 participants. The mean age of the participants was 22.1±5.2, and 56.2% were female. The rate of having COVID-19 among the participants was 27.8%. Of the students, 94.5% were vaccinated with the COVID-19 vaccines. The average correct response rate of the participants about the disease was 79.1±15.2%. Although the high rate of knowledge regarding the effectiveness of protective attitudes, it was seen that the rate of wearing a mask was 70.2% and just 49.9% of participants always avoid crowded areas. Conclusion: The approaches of young people, who can be the source of transmission, regarding COVID-19 disease and vaccines are extremely effective in controlling the pandemic. © 2022, Eurasian Society of Family Medicine. All rights reserved.
ABSTRACT
BACKGROUND AND AIM: SARS-CoV-2 has caused a pandemic and COVID-19 challenged both human and public health over the world. Different types of COVID-19 vaccines were developed against the disease virus with various techniques. In this research, it was aimed to evaluate the antibody responses induced by mRNA vaccines and inactivated vaccines or SARS-CoV-2 infection. METHODS: Between January and August 2021, 651 patients tested for immunoglobulin G antibody levels against the spike protien of SARS-CoV-2. Antibody levels(AU/mL) were detected by Chemiluminescence-Microparticle-Immunoassay, detection was carried on Abbott-Architect ci8200-Autoanalyzer. RESULTS: Among 651 patients 298 of them were vaccinated without previous COVID-19 history (77 mRNA, 221 inactivated), 123 were infected with SARSCoV-2 and not vaccinated, 58 were vaccinated after the infection (19 mRNA, 39 inactivated) while 172 of all did not have previous infection or vaccination history. of 172 patients 29 of them tested positive for anti-Spike antibody levels with a median value of 223.9. Inactivated vaccine induced antibody responses were significantly lower than mRNA vaccine induced levels (p=0.000, median:304.5, 7530.8 respectively). In previously infected population who were not vaccinated;higher antibody levels were observed than inactivated vaccine administred patients (p=0.000, median:737.1, 304.5 respectively), when compared to the patients who received mRNA vaccine antibody levels were found to be lower (p=0.000, median:737.1, 7530.8). Among the patients who were vaccinated after the infection;latterly mRNA vaccine administred patients were found to have higher antibody levels than patients who received inactivated vaccine after the infection (p=0.000, median:12070.4, 1183.9 respectively). CONCLUSIONS: Higher levels of antibody response were observed in patients who received mRNA vaccine when compared to those who received inactived vaccine or were infected with SARS-CoV-2. The highest levels were observed among patients who were infected then also received mRNA vaccine. This study whose preliminary data were examined should be supported by larger sample groups and longer follow-up with further studies.